LIFE:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund Hedged Units (CAD)

ETF | Sector Equity |

Last Closing

CAD 18.39

Change

-0.29 (-1.55)%

Market Cap

CAD 0.22B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-13 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.65 (+1.49%)

CAD 3.27B
ZWU:CA BMO Covered Call Utilities ETF

-0.06 (-0.55%)

CAD 1.83B
XIT:CA iShares S&P/TSX Capped Informa..

+0.57 (+0.83%)

CAD 0.72B
HTA:CA Harvest Tech Achievers Growth ..

+0.26 (+1.51%)

CAD 0.59B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.03 (-0.13%)

CAD 0.57B
TXF:CA First Asset Tech Giants Covere..

+0.37 (+1.90%)

CAD 0.57B
XHC:CA iShares Global Healthcare (CAD..

-1.64 (-2.57%)

CAD 0.56B
XUT:CA iShares S&P/TSX Capped Utiliti..

-0.09 (-0.31%)

CAD 0.35B
CWW:CA iShares Global Water Common Cl..

-0.19 (-0.31%)

CAD 0.30B
HUTL:CA Harvest Equal Weight Global Ut..

+0.07 (+0.39%)

CAD 0.29B

ETFs Containing LIFE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.52% 29% F 21% F
Dividend Return 0.99% 41% F 57% F
Total Return -3.53% 31% F 23% F
Trailing 12 Months  
Capital Gain -14.54% 11% F 12% F
Dividend Return 2.37% 58% F 43% F
Total Return -12.17% 11% F 12% F
Trailing 5 Years  
Capital Gain -12.84% 9% A- 18% F
Dividend Return 35.05% 76% C+ 77% C+
Total Return 22.20% 17% F 29% F
Average Annual (5 Year Horizon)  
Capital Gain -0.15% 20% F 29% F
Dividend Return 1.02% 14% F 26% F
Total Return 1.16% 53% F 41% F
Risk Return Profile  
Volatility (Standard Deviation) 6.86% 97% N/A 85% B
Risk Adjusted Return 14.84% 17% F 29% F
Market Capitalization 0.22B 65% D 47% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.